Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,285
datasets available to search
ShareScore release 0.9.0
Dataset results
2,285 results for “T-cells”
Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
ClinicalTrials.gov study NCT01110733. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of TQ-B3525 in Subjects With Relapsed/Refractory Peripheral T-cell Lymphoma（PTCL）
ClinicalTrials.gov study NCT04615468. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection
ClinicalTrials.gov study NCT01189786. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases
ClinicalTrials.gov study NCT06941129. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Ini
ClinicalTrials.gov study NCT06724237. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Immunotherapy With CD19 CAR T-cells for B-Cell Lymphoma, ALL and CLL
ClinicalTrials.gov study NCT02546739. IPD Sharing: Not stated. Countries: 1. Publications: 0.
DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT05680922. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of the Histone Deacetylase Inhibitor (HDACi) Quisinostat (JNJ-26481585) in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma
ClinicalTrials.gov study NCT01486277. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Lactoferrin Prophylaxis in VLBW and Regulator T-cells
ClinicalTrials.gov study NCT01287507. IPD Sharing: Not stated. Countries: 1. Publications: 0.
T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors
ClinicalTrials.gov study NCT00433407. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assessing An Oral JAK1 Inhibitor, Golidocitinib, in Patients Who Have Newly Diagnosed Peripheral T-Cell Lymphoma (JACKPOT23)
ClinicalTrials.gov study NCT07032532. IPD Sharing: NO. Countries: 1. Publications: 0.
Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL)
ClinicalTrials.gov study NCT03938987. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cu
ClinicalTrials.gov study NCT07055477. IPD Sharing: YES. Countries: 1. Publications: 0.
Relapsed/Refractory Large B-cell Lymphoma With NT-I7 Post-CD19 CAR T-cell Therapy
ClinicalTrials.gov study NCT05075603. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study on Anti-PD-1 Plus Lenalidomide and Azacitidine in Relapsed/Refractory Peripheral T-cell Lymphoma
ClinicalTrials.gov study NCT05182957. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Open-label Study Evaluating The Safety And Efficacy of Concomitant Administration of Anti-CD19 CAR T-cell Therapy and Lenalidomide in Refractory/Relapsed Chronic Lymphocytic Leukemia Patien
ClinicalTrials.gov study NCT06762431. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Investigation of the Effects of Oxidized Antigens on the T-Cell Response and the Epigenetic Reprogramming of Neutrophils in Lung Diseases - OXIGENE -
ClinicalTrials.gov study NCT07386912. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell Lymphoma
ClinicalTrials.gov study NCT02616965. IPD Sharing: NO. Countries: 1. Publications: 0.
T-cell Response-Flu Risk in Older Adults
ClinicalTrials.gov study NCT00138398. IPD Sharing: Not stated. Countries: 1. Publications: 0.
High Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic Transplant
ClinicalTrials.gov study NCT01941680. IPD Sharing: Not stated. Countries: 2. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.